Skip to main content
Fig. 5 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 5

From: Can positron emission tomography–computed tomography-based three target lesions' total lesion glycolysis predict therapeutic response in Hodgkin Lymphoma?

Fig. 5

Coronal MIP and Axial fused images of PET/CT of a male patient, 32 years old, presented with stage II HL. On the left, the initial film shows two target lesions (left cervical amalgamated LN with SUV max = 11.2 g/ml, MTV = 28.7cm3 and TLG = 279.7 g and amalgamated mediastinal nodal mass with SUV max = 12.2 g/ml, MTV = 3624cm3 and TLG = 2777.9 g). On the right, the interim film shows SUV max = 12 g/ml, MTV = 69.16cm3 and TLG = 552.2 g of cervical lesion, SUV max = 11.3 g/ml, MTV = 165cm3 and TLG = 1605.7 g of mediastinal lesion and denovo left hilar LN SUV max = 11 g/ml, MTV = 2.95cm3 and TLG = 28.9 g denoting progressive metabolic response (non-CR group)

Back to article page